Market Newsdesk

Maiden S-K 1300 economic study represents only the ST1 Nd-Pr rare earth deposit within the Sarfartoq REE carbonatite district

At 2025 consumption levels, the NdPr oxide Sarfartoq is expected to produce annually from ST1 alone would represent approximately 34% of all NdPr oxide refined outside China

CHARLOTTE, N.C., Aug. 25, 2026 (GLOBE NEWSWIRE) — via IBN – Greenland Mines Ltd (Nasdaq: GRML) (“Greenland Mines” or the “Company”), a Western-aligned critical minerals developer, today announced that the Company has released an independent Initial Assessment (“IA”) on the Sarfartoq Nd-Pr Rare Earth Element Project in southwest Greenland, a carbonatite-hosted, neodymium-praseodymium-rich rare earth deposit held under Greenland Exploration License MEL 2020-32.

The Sarfartoq Project is expected, under a high case, to have a pre-tax Net Present Value (NPV 8% real discount rate) of approximately up to US$2.05 billion at an IRR 118.6% including Indicated and Inferred Mineral Resources and up to US$1.49 billion at an IRR 92.7% including the Indicated but excluding Inferred Mineral Resources.

Western World Supply Significance

• Western Supply Chain: Neodymium and praseodymium supply outside China is limited; Sarfartoq is positioned to supply the critical magnet rare earth supply chain.
• Global Supply Significance: At 2025 consumption levels, Sarfartoq’s planned annual NdPr oxide production would represent approximately 34% of all NdPr oxide refined outside China, for each of the Project’s nine scheduled operating years.
• Strategic Western Partner: Neo Performance Materials Inc. (TSX: NEO) to become a strategic shareholder of Greenland Mines, retaining offtake rights (non-binding) on up to 60% of future Sarfartoq concentrate production for processing at NPM’s Silmet facility in Estonia — the only rare earth separation plant and magnet of scale currently operating at commercial scale in the European Union.

Resource and Technical Highlights

• Magnet Rare Earth Project: Neodymium-praseodymium-rich carbonatite deposit; neodymium and praseodymium account for approximately 84% of in-concentrate basket value. Hosted in conventional rare earth minerals already being processed at commercial scale elsewhere in the world today.
• Resource Base: Indicated Mineral Resources of 6.9 Mt @ 1.60% TREO (3,070 ppm Nd₂O₃, 963 ppm Pr6O₁₁) and Inferred Mineral Resources of 5.3 Mt @ 0.96% TREO (1,850 ppm Nd₂O₃, 572 ppm Pr6O₁₁), Hybrid open-pit and underground scenario.
• Landmark Study: First combined optimized open-pit and underground (“Hybrid”) Mineral Resource Estimate at Sarfartoq.
• Metallurgy: 2026 SGS Canada (Lakefield) test work confirming flotation concentrates of approximately 8.25% TREO at a design TREO recovery of 63.6%.
• Mine Plan: Nine-year mine life processing 12.2 million tons at 1.4 million tons per annum, at a delivered head grade of 1.32% TREO.
• Expanded Drill Database: 94 core holes (23,094 meters) of the Project’s 161-hole, approximately 35,800-meter database, including previously undisclosed 2023 infill drilling, versus roughly 50 holes supporting the 2012 estimate.

Project and Strategic Details

• Location: Approximately 60 km southwest of Kangerlussuaq and the international civilian and military airport in West Greenland. Exploration rights held under Greenland Exploration Licence MEL 2020-32 which covers 191 square-kilometers.
• Baseline investigations: Environmental baseline studies led by WSP Denmark; 2^nd year of investigations planned for September 2026 – a regulatory prerequisite for an exploitation license and mine production.

Upside Potential within the Sarfartoq Mineral Exploration License

• District-Scale Exploration: The ST1 deposit occupies well under one percent of the Company’s 191-square-kilometer Mineral Exploration license MEL 2020-32; five other known rare earth occurrences along the 32-kilometer outer ring structure remain largely untested, representing significant additional exploration potential beyond this Initial Assessment.

Dr. Bo Møller Stensgaard, President of Greenland Mines commented:

“This Initial Assessment shows the extraordinary scale of value embedded in just a small portion of Sarfartoq. Under our High case,

Sarfartoq is valued at over US$2 billion pre-tax with an IRR approaching 120%.

Neodymium and praseodymium are the two elements every high-performance magnet on earth depends on, and the West currently has almost nowhere to source them outside of China. Sarfartoq changes that equation.

“This Initial Assessment quantifies a de-risked and highly economic development case that puts this deposit in the top-tier of North American, European and western-world oriented upstream rare-earth magnet assets.

“At 2025 consumption levels,

the NdPr oxide Sarfartoq is expected to produce from ST1 alone would represent approximately 34% of all NdPr oxide refined outside China

, for each of the Project’s nine scheduled operating years — underscoring the global significance of a resource that reflects only a fraction of the license area’s potential.”

Results of the Initial Assessment

The results of the IA demonstrate that, under a high case, the Sarfartoq Project is expected to have a pre-tax Net Present Value (NPV 8% real discount rate) of approximately US$2.05 billion at an IRR 118.6% including Indicated and Inferred Mineral Resources and US$1.49 billion at an IRR 92.7% including the Indicated but excluding Inferred Mineral Resources.

The high case combines a basket price 15% above the base-case assumption, operating costs 15% below the base case and capital costs 20% below the base case, with physicals, mine schedule and metallurgical recovery held identically

The full IA report, prepared in the Technical Report Summary format under U.S. Securities and Exchange Commission Regulation S-K Subpart 1300 with an effective date of July 31, 2026, is a key study for advancing the development strategy for the Sarfartoq Project and can be viewed by visiting greenlandmines.com. Agricola Mining Consultants Pty Ltd conducted the IA.

On Aug. 24, 2026, Greenland Mines released the MRE (effective July 31, 2026) on the Sarfartoq Project in compliance with Regulation S-K 1300. The NPV in the IA was estimated based off the hybrid open-pit and underground Mineral Resource Estimate (MRE) of 6.9 million tons of Indicated Mineral Resources at 1.60% TREO and 5.3 million tons of Inferred Mineral Resources at 0.96% TREO.

Greenland Mines expects, as parts of its development plans for Sarfartoq, to conduct targeted infill drilling to upgrade Inferred Mineral Resources, pilot-scale metallurgical test work, mine engineering planning and continued environmental and social baseline studies led by WSP Denmark, advancing Sarfartoq toward a Pre-Feasibility Study.

A District-Scale Opportunity Beyond This Initial Assessment

Greenland Mines plans to deploy modern exploration techniques, including high-resolution, low-level drone-based magnetic surveys, to more efficiently identify and prioritize additional targets across the license ahead of ground-based follow-up. The Company’s technical team is scheduled to be back on the ground at Sarfartoq in September 2026 to advance this district-scale exploration program.

Dr. Bo Møller Stensgaard, President Greenland Mines Ltd., added:

“The Initial Assessment is built entirely on the ST1 deposit alone — just one target on a much larger system. At 2025 consumption levels, Sarfartoq’s planned production would supply roughly a third of all NdPr oxide refined outside China every year of its operating life.

“ST1 sits within the outer ring structure around the Sarfartoq carbonatite complex – a structure that circles the complex for roughly 32 kilometers within our exploration license that is 191-square-kilometers. Well under 1% of the land package has been explored in detail.

“Five other known rare earth occurrences — ST40, ST19, ST24, ST31 and ST43 — are known, but these have seen very limited exploration drilling, and still returned significant rare earth results — including at ST40, lying on the same outer ring structure 4 km away from ST1 on a coincident magnetic lows and radiometric thorium highs that mark the ring-dyke structure, which historical sampling indicates is more neodymium-enriched than ST1 itself. These occurrences remain largely still insufficiently explored, drill tested and developed – and this is alongside additional early-stage exploration targets across the complex.

“We see this as the foundation of a major new Western rare earth district, and we’re putting boots on the ground again this September to begin proving that out.”

Qualified Person

The scientific and technical information in this news release relating to the Initial Assessment has been reviewed and approved by Malcolm Castle, MAusIMM, of Agricola Mining Consultants Pty Ltd, an independent Qualified Person as defined under S-K 1300. The Mineral Resource Estimate referenced herein was prepared by Ronald G. Simpson, P.Geo., of GeoSim Services Inc., and Hassan Ghaffari, P.Eng., M.A.Sc., of Tetra Tech Canada Inc., each an independent Qualified Person.

About Greenland Mines Ltd

Greenland Mines Ltd is a Nasdaq-listed company with two operating divisions: (1) Mining, focused on the exploration and development of the Skaergaard Project in southeast Greenland and, subject to closing of the previously announced transaction, the Sarfartoq neodymium-praseodymium (Nd-Pr) rare earths project in southwest Greenland; and (2) Biotech, including Klotho’s KLTO-202 primary indication for ALS. The Company’s strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals, and select midstream processing opportunities, while advancing its broader North Atlantic Critical Metals Corridor vision linking Greenland resources with allied downstream jurisdictions and industrial infrastructure.

Cautionary Note Regarding Mineral Resources

Mineral Resources are not Mineral Reserves and do not have demonstrated economic viability. This news release uses the term “Initial Assessment,” a preliminary technical and economic study under Regulation S-K Subpart 1300, which may include Inferred Mineral Resources that are considered too speculative geologically to have modifying factors applied to them that would enable them to be categorized as Mineral Reserves. There is no certainty that the results of the Initial Assessment will be realized. No Mineral Reserves have been estimated for the Sarfartoq Project.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are often identified by words such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “potential,” “could,” “may,” “will,” “should,” “estimate” and similar expressions. These forward-looking statements include, but are not limited to, statements regarding the net present value, internal rate of return and the economic viability of the Sarfartoq Project (including High case sensitivity results), anticipated exploration and development plans, the timing and results of future studies including a Pre-Feasibility Study, the proposed acquisition of Neo North Star Resources, Inc. and associated offtake arrangements, as well as the financial position, financial performance, business strategy, expectations of our business and the plans and objectives of management for future operations. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this news release, forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target,” “designed to” or other similar expressions that predict or indicate future events or trends or that are not statements of historical facts. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements.

Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results could differ materially from those anticipated in forward-looking statements for many reasons, including the factors discussed under the “Risk Factors” section in the Company’s filings with the U.S. Securities and Exchange Commission. These forward-looking statements are based on information available as of the date of this news release, and expectations, forecasts and assumptions as of that date, involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Investor Contact and Corporate Communications:

[email protected]

Website: www.greenlandmines.com

Corporate Communications

:

IBN
Austin, Texas
IBN.Ai
512.354.7000 Office
[email protected]

The proposed acquisition is expected to provide the last step in power delivery to the core to complete Navitas’ grid-to-xPU high-power portfolio, accelerating its AI infrastructure strategy under Navitas 2.0 transformation

Anticipated benefits include:

• Enabling of all steps of power conversion to be addressed from ultra-high voltage grid down to core/xPU
• Doubling of Navitas’ 2030 serviceable addressable market (SAM) to over $8 billion
• Expansion of IP, engineering and technology capabilities across digital control, passive integration, leading-edge mixed signal, and advanced 2D/3D packaging
• Strengthening of mid- to long-term financial model through revenue acceleration and margin expansion, while maintaining its path to profitability

TORRANCE, Calif., Aug. 24, 2026 (GLOBE NEWSWIRE) — Navitas Semiconductor Corporation (Nasdaq: NVTS) (Navitas or the Company), the industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, today announced the signing of a definitive agreement to acquire Claros, Inc. (Claros) a power management solutions company developing vertical power delivery (VPD) and integrated voltage regulator (IVR) technology for next-generation AI data centers, in a transaction valued at up to approximately $232.8 million, based on the per share closing price of Navitas’ stock on August 21, 2026.

Navitas’ potential acquisition of Claros would extend the Company’s AI infrastructure portfolio from the grid all the way to the xPU by bringing industry-leading VPD and IVR capabilities that can directly power the high-current, high-speed processors at the heart of modern AI systems.

Today’s most advanced AI xPUs, GPUs, CPUs, TPUs, NPUs, and other accelerators – are running into a fundamental limit. Compute itself is not the bottleneck; it is the power delivery.

The new 800V high-voltage direct current (HVDC) architecture, paving the way for accelerated replacement of silicon by GaN and SiC high-power technologies, the core focus of Navitas 2.0, has started to address this problem, enabling higher-density power architecture and racks. However, on the last step, traditional voltage regulator modules (VRMs) push power sideways across the board, and as xPUs demand thousands of amps and near-instant response times, this lateral approach hits what Navitas refers to as a “power wall”. Bandwidth and compute performance are constrained by the limitations of existing power delivery systems.

Through the combination of Navitas and Claros, the Company expects to break through that wall all the way from grid-to-xPU. Claros’ VPD and IVR technologies stack power conversion, drive, control, and passives into a single, compact package. By placing this solution directly beneath or inside the chip package or printed circuit board, power travels only millimeters instead of inches. The result is ultra-fast transient response, dramatically lower impedance, higher efficiency at sub-volt levels, and the power density required for the next generation of AI compute.

This technology solution will be highly complementary to the GaN and high-voltage and ultra-high voltage SiC portfolio of Navitas, which enables the new 800V HVDC architecture, extending the high-density AI rack architecture in the first steps of the power conversion all the way to the core.

“The future of AI depends on delivering thousands of amps to increasingly power-hungry processors with unprecedented speed and precision,” said Chris Allexandre, President and CEO of Navitas. “The ‘power wall’ currently restricts next-gen xPUs in megawatt-scale server racks from achieving the next wave of AI performance. Combining Claros’ VPD and IVR technologies with Navitas’ GaN and high-voltage and ultra-high voltage SiC portfolio, we break the AI infrastructure power wall, advancing the entire power chain from grid-to-xPU. This acquisition follows our Navitas 2.0 transformation and significantly expands our addressable market, deepens our engagement with hyperscalers and AI power platform providers, as well as strengthens our leadership in AI infrastructure in terms of both capabilities and product solutions offering. As AI power demand accelerates, we are uniquely positioned to deliver greater value for our customers, while driving sustainable long-term growth.”

Dan Kultran, Co-founder & CEO of Claros, commented, “Since we launched Claros in 2024, we’ve moved to rapidly redefine the AI data center power system. Navitas is an ideal partner to enable a complete grid-to-xPU power portfolio, deepen and expand our engagement with leading xPU and power customers, and accelerate our next phase of growth. Our companies share a fast-paced, highly innovative culture and a commitment to advancing breakthrough power technologies for years to come. I am very excited for the opportunity to join Chris and the Navitas leadership team.

“Our integrated voltage regulator technology brings power conversion millimeters from the xPU, reducing board-level distribution losses, lowering heat generation, and improving the efficiency of processor-level power delivery. For AI accelerators and high-performance processors, this close-to-chip approach, with Claros’ IP in VPD array architecture, can enable higher compute density, lower operating costs, and more efficient deployment of next-generation AI infrastructure.”

Together, Claros’ VPD and IVR technologies also broaden Navitas’ technology, engineering and IP capabilities with deep expertise in digital control, passive integration, advanced 2D/3D packaging, and leading-edge power and analog mixed-signal technologies, while also adding standalone digital and controller solutions that complement the Company’s GaN portfolio.

The acquisition, when completed, is expected to more than double Navitas’ identified 2030 SAM to over $8 billion, adding at least $3.5 billion from the rapidly growing VPD and IVR markets. Combined with Navitas’ existing $3.5 billion SAM for GaN and HV/UHV SiC and approximately $1 billion from new junction field-effect transistor technology, the acquisition is expected to significantly expand Navitas’ opportunity across the complete grid-to-xPU power chain.

Navitas’ current short-to mid-term financial model and strategy, under its Navitas 2.0 transformation, remain unchanged. Claros’ VPD and IVR technologies provide an additional growth accelerator from 2028/2029 onward alongside Navitas’ strong organic 800V HVDC GaN and SiC growth in AI infrastructure. The Company remains committed to its path toward profitability and does not expect a material change from its previous timeline.

Transaction Structure

Under the terms of the definitive merger agreement, Navitas will acquire Claros in a transaction valued up to approximately $232.8 million, comprised of approximately $216.0 million to be paid at closing in a combination of cash and shares of the Company’s Class A common stock, par value $0.0001 per share (Common Stock), and the remainder of which will be paid in shares of Common Stock on the achievement of certain business milestones during the two years following the closing date. The value of shares of Common Stock that comprise the merger consideration was determined based on the closing share price of a share of Common Stock on August 21, 2026, which was $12.97 (the Reference Price).

In addition, certain continuing Claros employees will be eligible to receive performance based compensation under the Company’s equity incentive plan, payable in shares of Common Stock, having a value of approximately $28.9 million based on the Reference Price, and based on the achievement of these same business milestones. The transaction has been unanimously approved by the boards of directors of both companies and is expected to close before year-end, subject to customary closing conditions, including applicable regulatory approvals.

About Navitas

Navitas Semiconductor (Nasdaq: NVTS) is a next-generation power semiconductor leader in gallium nitride (GaN), and IC integrated devices, and high-voltage silicon carbide (SiC) technology, driving innovation across AI data centers, performance computing, energy and grid infrastructure, and industrial electrification. With more than 30 years of combined expertise in wide-bandgap technologies, GaNFast™ power ICs integrate GaN power, drive, control, sensing, and protection, delivering faster power delivery, higher system density, and greater efficiency. GeneSiC™ high-voltage SiC devices leverage patented ‘trench-assisted planar technology’ to provide industry-leading voltage capability, efficiency, and reliability for medium-voltage grid and infrastructure applications. Navitas has over 300 patents issued or pending and is the world’s first semiconductor company to be CarbonNeutral®-certified.

Navitas Semiconductor, GaNFast, GaNSense, GeneSiC, and the Navitas logo are trademarks or registered trademarks of Navitas Semiconductor Limited and affiliates. All other brands, product names, and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

About Claros

Claros is a power management solutions company that’s leveraging innovative hardware and software to make AI infrastructure more efficient, more resilient, and more sustainable. By driving down the cost and complexity of power delivery and leveraging innovative hardware and software, the company seeks to decrease energy consumption, optimize power delivery, increase compute performance, and maximize the efficiency of AI operations. Founded in 2024, Claros is backed by Red Cell Partners, General Catalyst, Systemiq Capital, VIPC, and other investors.

Advisors

Connected Vision Advisors (CVA) and Needham & Company served as financial advisors to Navitas. Cozen O’Connor served as legal advisor to Navitas, and DLA Piper served as legal advisor to Claros.

No Offer or Solicitation

This communication is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended.

Forward-Looking Statements

Any forward-looking statements contained in this release are included pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws.  From time to time, oral or written forward-looking statements may also be included in other information released to the public. These forward-looking statements are intended to provide The Company’s and Claros’ respective management’s current expectations or plans for the Company’s future operating and financial performance, based on assumptions currently believed to be valid. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “project,” “may,” “will,” “would,” “could,” “should,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these words. All forward-looking statements involve risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. These statements, including statements regarding the merger (the Mergers) contemplated by that certain Agreement and Plan of Merger (the Merger Agreement), by and among the Company, Claros, Compass Merger Sub 1 Inc., Compass Merger Sub 2 LLC, and Shareholder Representative Services LLC, the expected timing of the closing of the Mergers, and the anticipated benefits and prospects of the combined company, are based on management’s current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including, among others: the risk that the Mergers may not be completed in a timely manner or at all; the failure to satisfy the other conditions to the closing of the Mergers; the effect of the announcement, pendency or completion of the transaction on the market price of the Common Stock; the effects of business disruption resulting from the announcement or pendency of the Mergers; the diversion of management’s attention and resources from ongoing business operations; the effect of the transaction on the parties’ ability to retain and hire key personnel and to maintain relationships with customers, suppliers and other business partners; restrictions during the pendency of the transaction that may limit the parties’ ability to pursue business opportunities or strategic transactions; the risk that the anticipated benefits, synergies and cost savings may not be realized within the expected timeframe or at all; the difficulties and costs of integrating the two businesses; significant transaction costs and/or unknown or inestimable liabilities; the occurrence of any event that could give rise to termination of the Merger Agreement; the risk of stockholder litigation in connection with the transaction; the impact of macroeconomic and market conditions, including economic downturns, international conflict, trade disputes and tariffs; and the other risks identified in the Company’s filings with the SEC. There can be no assurance that the Mergers will in fact be consummated in the manner described or at all. These forward-looking statements speak only as of the date of this report and neither the Company nor Claros undertakes any obligation to update any forward-looking statement, except as required by applicable law.

Contact Information

Navitas Semiconductor
Vipin Bothra
[email protected]

Claros
[email protected]

Navitas Investor Contacts

Leanne Sievers | Brett Perry
Shelton Group
[email protected]

PR Image

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0db4c91b-e2c5-42f0-8c35-cf57ad62ba0d

AUSTIN, Texas, Aug. 24, 2026 (GLOBE NEWSWIRE) — Digital Realty (NYSE: DLR), the world’s largest cloud- and carrier-neutral data center platform, today announced it has been selected under Singapore’s second Data Center Call for Application (DC-CFA2), with a provisional allocation of 50 megawatts (MW) of capacity to develop a new data center at Jurong Town Corporation’s low-carbon data center park on Jurong Island – a milestone that reinforces Singapore’s position as a trusted, connected and sustainable digital infrastructure hub for Asia.

The selection marks the next phase of Digital Realty’s long-term growth in Singapore and will expand the company’s ability to support customers deploying the next wave of AI inference, high-performance computing and enterprise digital workloads across Asia Pacific. Purpose-built for Singapore’s digital economy priorities, the new facility will be designed to meet DC-CFA2’s requirements for best-in-class energy efficiency and power more than 50% of its capacity through green energy pathways.

Digital Realty was selected through an open competitive process led by the Singapore Economic Development Board (EDB) and the Infocomm Media Development Authority (IMDA). The awarded proposals were recognized for their ability to strengthen Singapore’s position as a trusted hub for AI, digital infrastructure and network connectivity, as well as to contribute to innovation and economic development, and advance the country’s sustainability objectives.

“Singapore has long been a strategic market for Digital Realty, and we are honored to be selected under DC-CFA2 at such an important moment for the country’s digital future,” said Serene Nah, Managing Director and Head of Asia Pacific, Digital Realty.

“Through DC-CFA2, we plan to expand on Jurong Island with next-generation AI-ready infrastructure. Sustainability is central to how we operate at Digital Realty, and we are committed to scaling responsibly as demand grows. We are grateful to the Singapore Government, lead agencies, our customers and partners for their continued trust and collaboration, and to our employees whose dedication makes this possible. We look forward to providing additional infrastructure to sustainably serve our customers in this leading global digital hub,” she continued.

Singapore has been a cornerstone of Digital Realty’s Asia Pacific strategy since establishing operations in the country in 2010. Today, it is home to Digital Realty’s regional Asia Pacific headquarters, Global Command Center, and three operational data centers with approximately 84 MW of combined capacity – giving the company a deep operating base from which to support Singapore’s continued growth as a regional digital hub.

Demand for digital infrastructure continues to grow as organizations expand cloud adoption, digital services, and enterprise data processing. AI is accelerating this growth across industries, including financial services, technology, logistics, and healthcare – sectors where Singapore plays an important regional role. As enterprises increasingly deploy AI in production, infrastructure requirements are also evolving. AI inference requires workloads to be located closer to users and enterprise data, supported by strong connectivity, resilience, and security.

Singapore’s combination of connectivity, trusted governance, and highly developed digital ecosystem positions it to play an increasingly important role in supporting these workloads across the region. Once operational, Digital Realty’s fourth Singapore data center is expected to strengthen this role by expanding the capacity available for high-value AI and enterprise deployments, connecting customers to its global PlatformDIGITAL^® ecosystem. The new facility will expand Digital Realty’s interconnected Singapore campus and is connected globally via ServiceFabric^®, a service orchestration platform that connects the campus with other Digital Realty and 3^rd party data centers globally to enable seamless connectivity, data exchange, and workload deployment across sites.

The new Jurong Island facility will also build on Digital Realty’s longstanding sustainability initiatives in Singapore. The company’s existing Singapore operations already achieve 100% renewable energy coverage through direct retail energy agreements with Tuas Power. Digital Realty has also collaborated with IMDA on Singapore’s tropical data center standard, demonstrating that higher chilled-water operating temperatures can improve energy efficiency without compromising operational resilience.

Drawing on the tropical data center standard, Digital Realty increased operating temperatures by 2°C across two data halls, reducing overall energy consumption by approximately 2-3% during the pilot period. In addition, Digital Realty uses sophisticated Building Management Systems to monitor more than 30,000 infrastructure points across its Singapore facilities, including real-time Power Usage Effectiveness (PUE).

Digital Realty plans to continue investing in resilient digital infrastructure, advancing energy and resource efficiency, and deepening local partnerships that support innovation, talent development and Singapore’s long-term digital competitiveness.

About Digital Realty

Digital Realty brings companies and data together by delivering the full spectrum of data center, colocation, and interconnection solutions. PlatformDIGITAL®, the company’s global data center platform, provides customers with a secure data meeting place and a proven Pervasive Datacenter Architecture (PDx®) solution methodology for powering innovation, from cloud and digital transformation to emerging technologies like artificial intelligence (AI), and efficiently managing Data Gravity challenges. Digital Realty gives its customers access to the connected data communities that matter to them with a global data center footprint of 300+ facilities in 55+ metros across 30+ countries on six continents. To learn more about Digital Realty, please visit digitalrealty.com or follow us on LinkedIn and X.

For Additional Information

Media Contact
Joyce Ng
Digital Realty
[email protected]

Investor Relations
Jordan Sadler / Jim Huseby
Digital Realty
(737) 281 – 0101
[email protected]

Safe Harbor Statement

This press release contains forward-looking statements which are based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially, including statements related to the company’s partnerships and expected benefits, expected completion dates, emerging technologies, artificial intelligence, sustainability goals, certifications and strategy and potential impact from sustainability initiatives customer demand and the company’s strategy. For a list and description of risks and uncertainties, see the reports and other filings by the company with the U.S. Securities and Exchange Commission. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

THE WOODLANDS, TX, Aug. 24, 2026 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it has entered into a warrant inducement agreement with an investor (“Investor”) for the immediate exercise of certain outstanding warrants that the Company issued on July 15, 2026 (the “July 2026 Warrants”). Pursuant to a warrant inducement agreement, the Investor has agreed to exercise the outstanding July 2026 Warrants to purchase an aggregate of 857,462 shares of the Company’s common stock at the exercise price of $5.75. The resale of the shares of common stock issuable upon exercise of the July 2026 Warrants has been registered pursuant to an effective registration statement on Form S-3 (File No. 333-297760). The gross proceeds from the exercise of the warrants are expected to be approximately $4.9 million, prior to deducting financial advisory fees and estimated offering expenses.

Maxim Group LLC acted as warrant inducement agent and financial advisor in connection with the transaction.

In consideration for the immediate exercise of the existing warrants in cash, the Company also agreed to issue to the Investor unregistered Series E-1 warrants to purchase an aggregate of 535,913 shares of the Company’s common stock, and unregistered Series E-2 warrants to purchase an aggregate of 535,913 shares of the Company’s common stock (collectively, the “New Warrants”). The New Warrants will each have an exercise price of $6.25 per share, will be exercisable upon issuance, and will expire on the five year anniversary of the date of issuance. The Company has agreed to file a registration statement with the Securities and Exchange Commission (“SEC”) covering the resale of the shares of common stock issuable upon exercise of the New Warrants.

The closing of the warrant exercise transaction is expected to occur on or about August 26, 2026, subject to satisfaction of customary closing conditions.

The New Warrants described above are being offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the “1933 Act”) and, along with the shares of common stock issuable upon their exercise, have not been registered under the 1933 Act, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission (“SEC”) or an applicable exemption from such registration requirements.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Autonomix Medical, Inc.

Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.

We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.

For more information, visit autonomix.com and connect with the Company on X, LinkedIn, Instagram and Facebook.

Forward Looking Statements

Some of the statements in this release are “forward-looking statements,” which involve risks and uncertainties. Forward-looking statements include, without limitation, the satisfaction of customary closing conditions related to the warrant transaction and the completion of the warrant transaction. Such forward-looking statements can be identified by the use of words such as “should,” “might,” “may,” “intends,” “anticipates,” “believes,” “estimates,” “projects,” “forecasts,” “expects,” “plans,” and “proposes.”

Although Autonomix believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements, including, but not limited to, the expected completion, timing and size of the warrant transaction, the intended use of proceeds from the transaction and Autonomix’s ability to file a registration statement registering the resale of the securities sold in the transaction. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” and elsewhere in the Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (“SEC”) on May 27, 2026, and from time to time, our other filings with the SEC. Forward-looking statements speak only as of the date of this press release and Autonomix does not undertake any duty to update any forward-looking statements except as may be required by law.

Investor and Media Contact

JTC Team, LLC
Jenene Thomas
908-824-0775
[email protected]

• Scheme Exchange Ratio determined at 0.111 pursuant to the terms of the merger agreement
• Scheme of arrangement expected to become effective on September 3, 2026, with Barinthus Bio ADSs expected to cease trading on Nasdaq prior to market open
• Topco common stock expected to commence trading on Nasdaq under the ticker symbol “CLYD” following completion of the proposed combination with Clywedog

GERMANTOWN, Md., Aug. 24, 2026 (GLOBE NEWSWIRE) — Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“Barinthus Bio,” or the “Company”), today provided an update regarding the anticipated closing of its proposed combination with Clywedog Therapeutics, Inc. (“Clywedog”) in an all-stock transaction.

Notice of Delisting and Transfer of Listing.

On August 24, 2026, in connection with the scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006 (the “Scheme”), which is expected to become effective on September 3, 2026 and is contemplated by the Agreement and Plan of Merger, dated September 29, 2025, by and among the Company, Beacon Topco, Inc., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Topco”), Cdog Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Topco, and Clywedog (as amended, the “Merger Agreement”), the Company notified The Nasdaq Stock Market, LLC (“Nasdaq”) of its intent to withdraw the listing of the Company’s American Depositary Shares (the “ADSs”) from Nasdaq following the effectiveness of the Scheme and requested Nasdaq file a Notification of Removal from Listing and/or Registration on Form 25 with the Securities and Exchange Commission (the “SEC”) to delist the ADSs from Nasdaq and deregister the ADSs under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Upon effectiveness of the Form 25, the Company intends to file with the SEC a Form 15 under the Exchange Act, requesting the deregistration of the ADSs and the suspension of the Company’s reporting obligations under Sections 13 and 15(d) of the Exchange Act. Trading of the ADSs on Nasdaq is expected to halt prior to the opening of trading on September 3, 2026. Following the completion of the transactions contemplated by the Merger Agreement, Topco will be renamed “Clywedog Therapeutics Holdings, Inc.,” and its common stock will be listed on Nasdaq under the ticker symbol “CLYD.”

Determination of the Scheme Exchange Ratio

On August 24, 2026, pursuant to the terms of the Merger Agreement, the board of directors of the Company (the “Board”) determined that the Scheme Exchange Ratio (as defined in the Merger Agreement) is 0.111, which ensures that the price of the shares in Topco’s common stock to be issued in exchange for the Scheme Shares (as defined in the Merger Agreement) would be sufficient to satisfy the minimum price requirement appliable to the listing of Topco’s common stock on Nasdaq.

The Merger Exchange Ratio (as defined in the Merger Agreement) will be determined as of immediately prior to the closing of the merger based on the Scheme Exchange Ratio as finally determined by the Board, any adjustments as provided in the Merger Agreement and to maintain the agreed ownership split of Topco following closing of the transaction.

Announcement of Date of Hearing

The Company’s application in respect of the transactions contemplated within the Merger Agreement is directed to be heard before a High Court Judge at the Royal Courts of Justice, The Rolls Building, 7 Rolls Building, Fetter Lane, London, United Kingdom, EC4A 1NL on September 1, 2026.

About Barinthus Bio

Barinthus Biotherapeutics (NASDAQ: BRNS) is a clinical-stage biopharmaceutical company developing novel immunotherapeutic candidates designed to guide the immune system to overcome autoimmunity and chronic infectious diseases. Helping people and their families living with serious diseases is the guiding principle at the heart of Barinthus Bio. With a focused pipeline built around its proprietary platform technologies, Barinthus Bio is advancing immunotherapeutic product candidates in autoimmunity including: VTP-1000, which utilizes the Company’s SNAP-Tolerance Immunotherapy (SNAP-TI) platform and is designed to treat people with celiac disease. Barinthus Bio’s differentiated technology platform and therapeutic approach, coupled with deep scientific expertise and focus on clinical development, positions the Company to navigate towards delivering treatments that improve the lives of people with autoimmunity. For more information, visit www.barinthusbio.com.

Forward Looking Statements

This press release contains forward-looking statements regarding Barinthus Bio within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, which can generally be identified as such by use of the words “may,” “will,” “plan,” “forward,” “encouraging,” “believe,” “potential,” “expect,” and similar expressions, although not all forward-looking statements contain these identifying words. These forward-looking statements include, without limitation, express or implied statements regarding the expected effectiveness and timing of the Scheme, the expected timing of the suspension of trading, delisting and deregistration of the ADSs, and the determination of the Merger Exchange Ratio. Any forward-looking statements in this press release are based on management’s current expectations and beliefs and are subject to numerous risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, risks and uncertainties related to the success, cost and timing of the Company’s pipeline development activities and planned and ongoing clinical trials, including the risk that the timing for preliminary, interim or final data or initiation of clinical trials may be delayed, the risk that interim or topline data may not reflect final data or results, the Company’s ability to execute on strategy, regulatory developments, the risk that the Company may not achieve the anticipated benefits of our pipeline prioritization and corporate restructuring, the Company’s ability to fund its operations and access capital, the Company’s cash runway, including the risk that the estimate of the cash runway may be incorrect, the risk that the proposed transaction may not be completed in a timely manner or at all, which may adversely affect our business and the price of our securities, the risk that that the proposed transaction may involve unexpected costs, liabilities or delays, or divert management’s attention from our ongoing business operations, the risk of any legal proceedings related to the proposed transaction or otherwise, or the impact of the proposed transaction thereupon, the risk that the anticipated benefits of the proposed transaction may otherwise not be fully realized or may take longer to realize than expected, risks relating to the value of the combined company securities to be issued in the proposed transaction, the risks associated with global economic uncertainty, including disruptions in the banking industry, the conflicts in Ukraine, Iran, Israel and Gaza, the disruptions in U.S. federal government operations, tariffs imposed by the U.S. and other countries, and the other risks identified in the Company’s filings with the Securities and Exchange Commission (the “SEC”), including the Company’s most recent annual report on Form 10-K and subsequent filings the Company may make with the SEC. The Company cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. The Company expressly disclaims any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements.

Additional Information and Where to Find It

In connection with the proposed transaction, the combined company plans to file with the SEC and mail or otherwise provide to Barinthus Bio’s investors and security holders a registration statement on Form S-4 that will contain a joint proxy statement/prospectus (the “Registration Statement”). BARINTHUS BIO’S INVESTORS AND SECURITY HOLDERS ARE URGED TO CAREFULLY READ THE REGISTRATION STATEMENT IN ITS ENTIRETY WHEN IT BECOMES AVAILABLE AND ANY OTHER DOCUMENTS FILED BY BARINTHUS BIO WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION OR INCORPORATED BY REFERENCE THEREIN BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND THE PARTIES TO THE PROPOSED TRANSACTION.

Investors and security holders may obtain a free copy of the Registration Statement and other documents that the combined company files with the SEC (when available) from the SEC’s website at www.sec.gov or at investors.barinthusbio.com.

No Offer or Solicitation

This press release is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, nor shall there be any offer, solicitation or sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law.

Participants in the Solicitation

Clywedog, Barinthus Bio and their respective directors, executive officers, other members of management, certain employees and other persons may be deemed to be participants in the solicitation of proxies from the security holders of Barinthus Bio in connection with the proposed transaction. Security holders may obtain information regarding the names, affiliations and interests of Barinthus Bio’s directors and executive officers in Barinthus Bio’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on March 13, 2026. To the extent holdings of Barinthus Bio’s securities by Barinthus Bio’s directors and executive officers have changed since the amounts set forth in such Annual Report on Form 10-K, such changes have been or will be reflected on subsequent Statements of Changes in Beneficial Ownership on Form 4 filed with the SEC. Additional information regarding the interests of such individuals in the proposed transaction will be included in the Registration Statement relating to the proposed transaction when it is filed with the SEC. These documents (when available) may be obtained free of charge from the SEC’s website at www.sec.gov and Barinthus Bio’s website at investors.barinthusbio.com.

Company contact:

[email protected]